Delcourt, T.; Vanneste, K.; Soumali, M.R.; Coucke, W.; Ghislain, V.; Hebrant, A.; Van Valckenborgh, E.; De Keersmaecker, S.C.J.; Roosens, N.H.; Van De Walle, P.;
et al. NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program. Cancers 2020, 12, 3180.
https://doi.org/10.3390/cancers12113180
AMA Style
Delcourt T, Vanneste K, Soumali MR, Coucke W, Ghislain V, Hebrant A, Van Valckenborgh E, De Keersmaecker SCJ, Roosens NH, Van De Walle P,
et al. NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program. Cancers. 2020; 12(11):3180.
https://doi.org/10.3390/cancers12113180
Chicago/Turabian Style
Delcourt, Thomas, Kevin Vanneste, Mohamed Rida Soumali, Wim Coucke, Vanessa Ghislain, Aline Hebrant, Els Van Valckenborgh, Sigrid C. J. De Keersmaecker, Nancy H. Roosens, Philippe Van De Walle,
and et al. 2020. "NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program" Cancers 12, no. 11: 3180.
https://doi.org/10.3390/cancers12113180
APA Style
Delcourt, T., Vanneste, K., Soumali, M. R., Coucke, W., Ghislain, V., Hebrant, A., Van Valckenborgh, E., De Keersmaecker, S. C. J., Roosens, N. H., Van De Walle, P., Van Den Bulcke, M., & Antoniou, A.
(2020). NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program. Cancers, 12(11), 3180.
https://doi.org/10.3390/cancers12113180